Bayesian Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-38,922
| Closed | -$700K | – | 776 |
|
2020
Q2 | $700K | Buy |
+38,922
| New | +$700K | 0.15% | 190 |
|
2020
Q1 | – | Sell |
-11,222
| Closed | -$268K | – | 1044 |
|
2019
Q4 | $268K | Buy |
+11,222
| New | +$268K | 0.05% | 458 |
|
2019
Q2 | – | Sell |
-44,400
| Closed | -$1.54M | – | 744 |
|
2019
Q1 | $1.54M | Buy |
44,400
+14,500
| +48% | +$503K | 0.3% | 102 |
|
2018
Q4 | $584K | Buy |
+29,900
| New | +$584K | 0.12% | 247 |
|
2018
Q1 | – | Sell |
-7,961
| Closed | -$388K | – | 904 |
|
2017
Q4 | $388K | Buy |
+7,961
| New | +$388K | 0.08% | 367 |
|
2017
Q3 | – | Sell |
-12,861
| Closed | -$722K | – | 704 |
|
2017
Q2 | $722K | Buy |
+12,861
| New | +$722K | 0.27% | 130 |
|